Tech Company Financing Transactions
Syntonix Pharmaceuticals Funding Round
Syntonix Pharmaceuticals, based in Waltham, secured $2 million from Alta Partners, Bay City Capital and Pappas Ventures.
Transaction Overview
Company Name
Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
9 Fourth Avenue
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Not Recorded
Overview
Syntonix is developing next generation biopharmaceuticals that enable better treatment options for patients with devastating chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Ripple
Browse more venture capital transactions:
Prev: 3/31/2006: Attensity venture capital transaction
Next: 3/31/2006: PicksPal venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs